- Home
- FSBC vs ARVN Comparison
FSBC vs ARVN Comparison
Compare FSBC & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSBC
- ARVN
- Stock Information
- Founded
- FSBC 2002
- ARVN 2015
- Country
- FSBC United States
- ARVN United States
- Employees
- FSBC N/A
- ARVN N/A
- Industry
- FSBC Banks
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- FSBC Finance
- ARVN Health Care
- Exchange
- FSBC Nasdaq
- ARVN Nasdaq
- Market Cap
- FSBC 741.2M
- ARVN 676.2M
- IPO Year
- FSBC 2021
- ARVN 2018
- Fundamental
- Price
- FSBC $35.20
- ARVN $9.57
- Analyst Decision
- FSBC Buy
- ARVN Buy
- Analyst Count
- FSBC 6
- ARVN 23
- Target Price
- FSBC $37.83
- ARVN $17.80
- AVG Volume (30 Days)
- FSBC 78.3K
- ARVN 2.6M
- Earning Date
- FSBC 10-27-2025
- ARVN 11-05-2025
- Dividend Yield
- FSBC 2.31%
- ARVN N/A
- EPS Growth
- FSBC 19.48
- ARVN N/A
- EPS
- FSBC 2.69
- ARVN N/A
- Revenue
- FSBC $141,930,000.00
- ARVN $312,300,000.00
- Revenue This Year
- FSBC $31.86
- ARVN N/A
- Revenue Next Year
- FSBC $15.36
- ARVN N/A
- P/E Ratio
- FSBC $13.09
- ARVN N/A
- Revenue Growth
- FSBC 25.41
- ARVN 93.86
- 52 Week Low
- FSBC $22.22
- ARVN $5.90
- 52 Week High
- FSBC $37.74
- ARVN $28.83
- Technical
- Relative Strength Index (RSI)
- FSBC 57.38
- ARVN 54.45
- Support Level
- FSBC $34.20
- ARVN $9.01
- Resistance Level
- FSBC $37.63
- ARVN $10.18
- Average True Range (ATR)
- FSBC 1.22
- ARVN 0.40
- MACD
- FSBC -0.00
- ARVN -0.06
- Stochastic Oscillator
- FSBC 59.63
- ARVN 48.02
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.